JPS6045852B2 - Method for producing placental gonadotropic hormone - Google Patents
Method for producing placental gonadotropic hormoneInfo
- Publication number
- JPS6045852B2 JPS6045852B2 JP56197380A JP19738081A JPS6045852B2 JP S6045852 B2 JPS6045852 B2 JP S6045852B2 JP 56197380 A JP56197380 A JP 56197380A JP 19738081 A JP19738081 A JP 19738081A JP S6045852 B2 JPS6045852 B2 JP S6045852B2
- Authority
- JP
- Japan
- Prior art keywords
- urine
- hcg
- adsorbent
- aqueous solution
- eluate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000005556 hormone Substances 0.000 title claims description 5
- 229940088597 hormone Drugs 0.000 title claims description 5
- 230000003169 placental effect Effects 0.000 title claims description 4
- 230000001456 gonadotroph Effects 0.000 title 1
- 239000003463 adsorbent Substances 0.000 claims description 23
- 210000002700 urine Anatomy 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 10
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 102000006771 Gonadotropins Human genes 0.000 claims description 3
- 108010086677 Gonadotropins Proteins 0.000 claims description 3
- 239000002622 gonadotropin Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 description 17
- 238000010828 elution Methods 0.000 description 13
- 238000001179 sorption measurement Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000005995 Aluminium silicate Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 235000012211 aluminium silicate Nutrition 0.000 description 7
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 5
- 239000005695 Ammonium acetate Substances 0.000 description 5
- 235000019257 ammonium acetate Nutrition 0.000 description 5
- 229940043376 ammonium acetate Drugs 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 229910052681 coesite Inorganic materials 0.000 description 3
- 229910052906 cristobalite Inorganic materials 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 229910052682 stishovite Inorganic materials 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229910052905 tridymite Inorganic materials 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 description 2
- BYFGZMCJNACEKR-UHFFFAOYSA-N aluminium(i) oxide Chemical compound [Al]O[Al] BYFGZMCJNACEKR-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229910052593 corundum Inorganic materials 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229910001845 yogo sapphire Inorganic materials 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- BIGPRXCJEDHCLP-UHFFFAOYSA-N ammonium bisulfate Chemical compound [NH4+].OS([O-])(=O)=O BIGPRXCJEDHCLP-UHFFFAOYSA-N 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- PGZIKUPSQINGKT-UHFFFAOYSA-N dialuminum;dioxido(oxo)silane Chemical compound [Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O PGZIKUPSQINGKT-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明は胎盤性性腺刺戟ホルモン(HCG)の製造法に
関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing placental gonadotropin hormone (HCG).
HCGは分子量約30000〜40000の糖蛋白性ホ
ルモンで、胎盤で作られ、妊婦尿に含有されている。HCG is a glycoprotein hormone with a molecular weight of about 30,000 to 40,000, produced in the placenta and contained in pregnant women's urine.
妊婦尿からHCGを採取する方法は多数発表されている
が、代表的なものは安息香酸吸着法〔Kat2manら
、J、Biol、Chem、98739(1932)〕
、カオリン吸着法〔Brodlurgら9Pro、So
c、Exptl、Biol。Many methods have been published for collecting HCG from pregnant women's urine, but the most representative one is the benzoic acid adsorption method [Katman et al., J. Biol, Chem, 98739 (1932)].
, Kaolin adsorption method [Brodlurg et al. 9Pro, So
c, Exptl, Biol.
&Med、71228(1947)〕である。これらの
方法はいずれもHCGを選択的に吸着させることができ
ないので製品HCG中に異種物質が多く混在し、単位活
性の低い製品しか得られないなどの欠点がある。本発明
者は従来の方法の欠点を克服したより有利な製造法を確
立するために広範囲な研究を行つた。&Med, 71228 (1947)]. Since none of these methods can selectively adsorb HCG, there are drawbacks such as a large amount of different substances being mixed in the HCG product and only products with low unit activity being obtained. The inventor has conducted extensive research in order to establish a more advantageous manufacturing method that overcomes the drawbacks of conventional methods.
先ず、妊婦尿をイオン交換樹脂やイオン交換体に接触さ
せてHCGを捕集しようとしたが、原尿を用いた場合H
CGをよく吸着するイオン交換樹脂やイオン交換体はほ
とんどなく、また吸着しても溶出液としてΛ−アンモニ
ア水、IN塩化ナトリウム水溶液、50%アルコール、
40%アルコールや10%AcNH、を用いる各種の溶
出法で溶出率が40%を越えるものはなかつた。First, attempts were made to collect HCG by contacting pregnant woman's urine with an ion exchange resin or ion exchanger, but when using raw urine, HCG was collected.
There are almost no ion exchange resins or ion exchangers that adsorb CG well, and even if it does, the eluent may be Λ-ammonia water, IN sodium chloride aqueous solution, 50% alcohol,
No elution rate exceeded 40% using various elution methods using 40% alcohol or 10% AcNH.
また、2−3倍希釈の尿を用いた場合イオン交換樹脂や
交換体の種類によつてはHCGを吸着するものもあるが
各種溶出法で溶出率が70%を越えるものはなく、製品
の比活性は100〜5001U/ mg(蛋白質)にす
ぎ・ず、高価な吸着体を多量に必要とするなど工業的に
有利な方法ではないことが判明した。そこで、HCGの
製造に従来用いられている公知の吸着剤について尿中H
CG吸着の最適pHを調べ、そのpHで吸着を行い、州
一アンモニア水でフ溶出して第1表の成績を得た。In addition, when using 2-3 times diluted urine, some ion exchange resins and exchangers may adsorb HCG, but no elution rate exceeds 70% using various elution methods. The specific activity was only 100 to 5001 U/mg (protein), and it was found that this method was not industrially advantageous, as it required a large amount of expensive adsorbent. Therefore, with respect to known adsorbents conventionally used in the production of HCG, urinary H
The optimum pH for CG adsorption was investigated, adsorption was carried out at that pH, and the results shown in Table 1 were obtained by elution with Shuichi ammonia water.
なお、比活性は吸着率十以上のものにつき溶出成分をア
セトン・パウダーとして測定した。第1表から明らかな
ように、吸着率はカオリン系のものがよかつたが、溶出
率、比活性はよくなかつた。The specific activity was measured using acetone powder as the eluted component for those with an adsorption rate of 10 or more. As is clear from Table 1, the kaolin type had a good adsorption rate, but the elution rate and specific activity were poor.
それで、本発明者らはさらに広範囲の吸着剤について上
記同様の試験を行い第2表の結果を得た。Therefore, the present inventors conducted tests similar to those described above for a wider range of adsorbents and obtained the results shown in Table 2.
1)日本活性白土製カオリン系材料
2)林化成製 同
3)同 同
4)白石工業製同
75)富田製薬製ケイ酸アルミン酸ニマグネシウムすな
わち、上記多数の吸着剤よりも公知のカオリンの方がす
ぐれており、またカオリン中のHCG吸着因子としてA
l。1) Kaolin-based material manufactured by Japan Activated White Clay 2) Made by Hayashi Kasei 3) Same 4) Made by Shiraishi Kogyo 75) Tomita Pharmaceutical Co., Ltd. Dimagnesium aluminate silicate, that is, known kaolin is better than many of the adsorbents mentioned above. is excellent, and also has A as an HCG adsorption factor in kaolin.
l.
O3・SiO2,MgOなどが考えられるがアルミナ、
シリカ、マグネシアの単ク体はHCGを吸着しないこと
が判つた。続いてさらに種々の組成を有する合成吸着剤
について同様の試験を行つたところ、第3表に示すよう
に、合成ゼオライト、アルミナ水和物、水酸化アルミニ
ウム、炭酸水素ナトリウム分子化合物7はHCGを吸着
せず、ケイ酸マグネシウムは吸着、溶出率ともに劣り、
本発明の合成ケイ酸アルミニウム(アルミノケイ酸塩)
のみが吸着、脱着率、比活性のすべての点ですぐれた成
績を示しカオリンに遥かに勝る効果のあることが判明し
た。O3, SiO2, MgO, etc. are possible, but alumina,
It was found that silica and magnesia alone do not adsorb HCG. Subsequently, similar tests were conducted on synthetic adsorbents with various compositions, and as shown in Table 3, synthetic zeolite, alumina hydrate, aluminum hydroxide, and sodium bicarbonate molecular compound 7 adsorbed HCG. Magnesium silicate has poor adsorption and elution rates.
Synthetic aluminum silicate (aluminosilicate) of the present invention
Only kaolin showed excellent results in all aspects of adsorption, desorption rate, and specific activity, and was found to be far more effective than kaolin.
上記各表中、吸着および溶出率、比活性についての記号
は次の数値を示す。本発明は、以上述べたような知見に
基いて完成されたもので、妊婦尿を弱酸性で式Al2O
3・?IO2・XH2Oを有するケイ酸アルミニウムよ
りなる吸着剤に接触させて尿中の成分を吸着させ、吸着
剤から被吸着物をアルカリ性水溶液で溶出したのち溶出
液を弱酸性にして生成する沈澱を除去した残留液、また
は上記吸着物を低級アルコールとそれに可溶性の塩を含
有する水溶液で溶出した溶出液、から有効成分を採取す
ることを特徴とする胎盤性性腺刺戟ホルモンの製造法で
ある。In each of the above tables, the symbols for adsorption, elution rate, and specific activity indicate the following numerical values. The present invention has been completed based on the above-mentioned findings, and the urine of pregnant women is treated with weakly acidic acid with the formula Al2O.
3.? Components in the urine were adsorbed by contacting with an adsorbent made of aluminum silicate containing IO2. This is a method for producing placental gonadotropin hormone, which is characterized in that the active ingredient is collected from the residual liquid or the eluate obtained by eluting the adsorbed substance with an aqueous solution containing a lower alcohol and a salt soluble therein.
本発明の方法においては、妊婦尿をそのま)用いてもよ
いが、予めPH8−9、好ましくは8.5として夾雑す
るムコ多糖類等の不純物を沈澱させ、淵過その他の手段
により除去したものを用いるのが望ましい。吸着剤とし
て用いる式.Al2O3・Cf:)IO2・ボ。In the method of the present invention, pregnant women's urine may be used as it is, but the pH of pregnant women's urine may be adjusted to 8-9, preferably 8.5, and impurities such as mucopolysaccharides are precipitated and removed by filtering or other means. It is preferable to use something. Formula used as adsorbent. Al2O3・Cf:)IO2・Bo.
0を有するケイ酸アルミニウム(アルミノケイ酸塩、商
品名キヨーワード700協和化学工業製)はAl2O3
9〜13%、SiO258〜64%の合成ケイ酸アルミ
ニウム粉末であつて、本発明の目的を達しうる限り粒径
は特に限定されないが、吸着、脱着の操作法によつて下
記のような好ましい範囲がある。Aluminum silicate (aluminosilicate, trade name KYOWARD 700 manufactured by Kyowa Chemical Industry) having 0 is Al2O3
It is a synthetic aluminum silicate powder containing 9 to 13% SiO2 and 58 to 64% SiO2, and the particle size is not particularly limited as long as the object of the present invention can be achieved, but the particle size may be within the following preferred range depending on the adsorption and desorption operation method. There is.
尿と吸着剤の接触および吸着剤から被吸着物の溶出はバ
ッチ法、バッチ−カラム法、カラム法のいずれの操作法
によつて行いうる。吸着剤の好ましい粒径は、バッチ法
においては100〜200メッシュ、尿との接触をバッ
チ法で行い、溶出をカラムで行うバッチ−カラム法およ
びカラム法においては50−100メッシュである。The contact between the urine and the adsorbent and the elution of the adsorbed material from the adsorbent can be carried out by any of the batch method, batch-column method, and column method. The preferred particle size of the adsorbent is 100 to 200 mesh in a batch method, and 50 to 100 mesh in a batch-column method and a column method in which contact with urine is performed in a batch method and elution is performed in a column.
尿と吸着剤を接触させる際、尿は弱酸性とするのがよく
、特にPH約3−5とするのが好ましい。PH5を越え
るとHCGの吸着が阻害される傾向がある。吸着剤の使
用量が接触時間は特に限定されないが、実用上添加量は
尿1eあたり0.5−1.0gの吸着剤が好ましく、ま
た約2時間接触させるのが好ましい。When bringing the urine and the adsorbent into contact, the urine is preferably slightly acidic, particularly preferably at a pH of about 3-5. If the pH exceeds 5, HCG adsorption tends to be inhibited. The amount of adsorbent used and the contact time are not particularly limited, but in practice, the amount added is preferably 0.5-1.0 g of adsorbent per 1 e of urine, and the contact time is preferably about 2 hours.
溶出に用いるアルカリ性水溶液は中等度のアルカリ性が
よく、PHlO.5−12が好ましい。The alkaline aqueous solution used for elution is preferably moderately alkaline, with PHLO. 5-12 is preferred.
水溶液をアルカリ性とする材料は目的を達しうる範囲で
適宜選択できるが、好ましい例はボーアンモニア水や△
一炭酸ナトリウム水溶液(PHll)などである。被吸
着物を吸着剤からアルカリ性水溶液で溶出して得られた
溶出液からHCGを採取するには種々の方法を用いうる
。The material that makes the aqueous solution alkaline can be selected as appropriate within the range that achieves the purpose, but preferred examples are Bo's ammonia water and △
Examples include aqueous sodium monocarbonate solution (PHll). Various methods can be used to collect HCG from the eluate obtained by eluting the adsorbent from the adsorbent with an alkaline aqueous solution.
たとえば、溶出液を希塩酸などで弱酸性に調整して、硫
安などで塩析してHCGを沈澱させてもよく、またアセ
トンを加えて沈澱させてもよい。また、溶出は低級アル
コールとそれに可溶性の塩を含有する水溶液を用いても
行いうる。For example, the eluate may be adjusted to be weakly acidic with dilute hydrochloric acid or the like, and HCG may be precipitated by salting out with ammonium sulfate or the like, or acetone may be added to precipitate it. Elution can also be carried out using an aqueous solution containing a lower alcohol and a salt soluble therein.
低級アルコールとしては、たとえばメタノール、エタノ
ール、イソプロパノールなどが用いられる。低級アルコ
ールに可溶性の塩としては酢酸アンモニウム、ギ酸アン
モニウムなどが挙げられる。水溶液中のアルコール濃度
は余り高くない方がよい。Examples of lower alcohols used include methanol, ethanol, and isopropanol. Examples of salts soluble in lower alcohols include ammonium acetate and ammonium formate. It is better that the alcohol concentration in the aqueous solution is not too high.
アルコール濃度が約70%になるとHCGはほとんど溶
出しなくなる。また、塩濃度が高くなると、たとえば酢
酸アンモニウムの濃度が15%以上になると、HCGが
変性しやすくなる。好ましい水溶液の例はアルコール約
40%、酢酸アンモニウム約10%を含有するものであ
る。上記の低級アルコールと可溶性塩含有水溶液で溶出
して得られた溶出液に低級アルコールを加えればHCG
は沈澱する。When the alcohol concentration reaches about 70%, HCG hardly elutes. Furthermore, when the salt concentration increases, for example when the concentration of ammonium acetate exceeds 15%, HCG tends to be denatured. An example of a preferred aqueous solution is one containing about 40% alcohol and about 10% ammonium acetate. If a lower alcohol is added to the eluate obtained by elution with the above lower alcohol and aqueous solution containing a soluble salt, HCG
precipitates.
アルコールの添加量が少いと目的物の収率が悪くなり、
また多すぎると沈澱中に不純物が増加するので、通常溶
出液に対して約3倍量程度のアルコールを加えるのが好
ましい。以上のようにして沈澱として採取されるHCG
Lは一般に2000−30001U/Mg(蛋白質)に
達しさせることができ、これは従来の方法によるものに
対して5−1@の比活性に相当する。If the amount of alcohol added is small, the yield of the target product will be poor,
If the amount is too large, impurities will increase in the precipitate, so it is usually preferable to add about three times the amount of alcohol to the eluate. HCG collected as precipitate as described above
L can generally reach 2000-30001 U/Mg (protein), which corresponds to a specific activity of 5-1@ compared to that by conventional methods.
次に実施例を挙げてさらに詳しく本発明を説明する。Next, the present invention will be explained in more detail with reference to Examples.
7実施例1
妊娠2ケ月から6ケ月の妊婦尿50eを4N一水酸化ナ
トリウム液でPH8.5として生じた沈澱をP去した後
、泗一塩酸でPH3.5とし合成ケイ酸アルミニウム(
キヨーワード7凹協和化学工業製、200フメツシユ)
250gを加えて2時間接触させる。7 Example 1 50e of pregnant woman's urine from 2nd month to 6th month of pregnancy was adjusted to pH 8.5 with 4N sodium monohydroxide solution. After removing the precipitate, the pH was adjusted to 3.5 with Samichi hydrochloric acid. Synthetic aluminum silicate (
Keyword 7 concave manufactured by Kyowa Chemical Industry, 200 meters)
Add 250 g and leave in contact for 2 hours.
静置後、上清と吸着剤とを分離し、5.0eの水て吸着
剤を洗い、?−アンモニア水3.0eで溶出する。溶出
液をPH5.Oとして生じた沈澱を除いた液に流酸アン
モンを50%になるように加えてHCGを沈澱させた。
得られたHCGは15000001U1比活性は200
01U/Mg(蛋白質)、収率は91.2%であつた。After standing still, separate the supernatant and adsorbent, wash the adsorbent with 5.0e water, and wash the adsorbent with 5.0e water. - Elute with aqueous ammonia 3.0e. The eluate was adjusted to pH5. Ammonium sulfuric acid was added to the solution from which the precipitate formed as O was removed to a concentration of 50% to precipitate HCG.
The obtained HCG is 15000001U1 specific activity is 200
01 U/Mg (protein), yield was 91.2%.
実施例2妊娠2ケ月〜6ケ月の妊婦尿10eを実施例1
と同様にPH8.5として沈澱を除き希塩酸でPH3.
5とする。Example 2 Pregnant woman urine 10e from 2nd month to 6th month of pregnancy was collected in Example 1.
Similarly, adjust the pH to 8.5, remove the precipitate, and adjust the pH to 3. with dilute hydrochloric acid.
5.
例1と同様の合成ケイ酸アルミニウム(50〜100メ
ッシュ)100gを直径10Cr!lのカラムにつめ、
上記の処理尿を2e/時間の速さて流下し、水1.0e
で洗浄後40%エタノール・10%酢酸アンモニウム液
1.0′で溶出し溶出液500m1に3倍量の95%エ
タノールを加えてHCGを沈澱させた。回収されたHC
Gは2960001U1比活性は30001U/Mg(
蛋白質)、収率は85%であつた。実施例3妊娠2ケ月
〜6ケ月の妊婦尿50eを実施例1と同様にPH8.5
で処理して希HClでPH3.5として例1と同様の合
成ケイ酸アルミニウム(50〜100メッシュ)500
gを加えて2時間接触させる。100g of synthetic aluminum silicate (50-100 mesh) similar to Example 1 with a diameter of 10Cr! Pack into l column,
The above treated urine flows down at a rate of 2e/hour, and the water is 1.0e/hour.
After washing with 40% ethanol/10% ammonium acetate solution 1.0', HCG was precipitated by adding 3 times the volume of 95% ethanol to 500 ml of the eluate. recovered HC
G is 2960001U1 specific activity is 30001U/Mg (
protein), the yield was 85%. Example 3 Pregnant woman urine 50e from 2nd month to 6th month of pregnancy was treated with pH 8.5 in the same manner as in Example 1.
Synthetic aluminum silicate (50-100 mesh) as in Example 1 and adjusted to pH 3.5 with dilute HCl
g and leave in contact for 2 hours.
静置後吸着剤と上清と分離し、5.0eの水で吸着剤を
洗い、直径10cmのカラムにつめ、さらに5.0eの
水で洗浄後、5.0e(1)2N一炭酸ナトリウム水溶
液で溶出する。溶出液3.0eを希HClでPH5.O
として生じた沈澱を遠心分離後、硫酸アンモンを50%
になるように加えて、HCGの沈澱を得た。収率90.
2%比活性20001U/Mg(蛋白質)。実施例4
妊娠2ケ月〜6ケ月尿100eを実施例1と同様にPH
8.5で処理して希塩酸でPH3.5とし、例1と同様
の合成ケイ酸アルミニウム(200メッシュ)500g
を加えて2時間接触させる。After standing still, separate the adsorbent from the supernatant, wash the adsorbent with 5.0e of water, pack it into a column with a diameter of 10cm, further wash with 5.0e of water, and add 5.0e (1) 2N sodium monocarbonate. Elutes in aqueous solution. Eluate 3.0e was adjusted to pH 5.0 with dilute HCl. O
After centrifuging the resulting precipitate, ammonium sulfate was added to 50%
A precipitate of HCG was obtained. Yield: 90.
2% specific activity 20001 U/Mg (protein). Example 4 100e of urine from 2nd month to 6th month of pregnancy was pH-treated in the same manner as in Example 1.
8.5 and adjusted to pH 3.5 with dilute hydrochloric acid, and 500 g of synthetic aluminum silicate (200 mesh) as in Example 1.
and leave in contact for 2 hours.
静置後上清と”吸着剤とを分離し5.0eの水で洗浄後
40%メタノール・10%酢酸アンモニウム液5.0′
で溶出する。溶出液4.0eにメタノール12.0eを
加えてHCGの沈澱を得た。回収されたHCGは250
00001U1比活性は27001U/Mg(蛋白質)
、収率は85%であつた。After standing still, separate the supernatant and adsorbent, wash with 5.0e of water, and add 40% methanol/10% ammonium acetate solution 5.0'
Elutes with 12.0e of methanol was added to 4.0e of the eluate to obtain a precipitate of HCG. The amount of HCG recovered was 250
00001U1 specific activity is 27001U/Mg (protein)
The yield was 85%.
Claims (1)
−xH_2Oを有するケイ酸アルミニウムよりなる吸着
剤と接触させて尿中の成分を吸着させ、吸着剤から被吸
着物をアルカリ性水溶液で溶出したのち溶出液を弱酸性
にして生成する沈澱を除去した残留液、または上記吸着
物を低級アルコールとそれに可溶性の塩を含有する水溶
液で溶出した溶出液、から有効成分を採取することを特
徴とする胎盤性性腺刺戟ホルモンの製造法。1 Pregnant woman urine is slightly acidic and the formula Al_2O_3・9SiO_2
The components in urine are adsorbed by contacting with an adsorbent made of aluminum silicate containing -xH_2O, the adsorbed substances are eluted from the adsorbent with an alkaline aqueous solution, and the eluate is made weakly acidic to remove the resulting precipitate. 1. A method for producing placental gonadotropin hormone, which comprises collecting an active ingredient from a liquid or an eluate obtained by eluting the adsorbed substance with an aqueous solution containing a lower alcohol and a salt soluble therein.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56197380A JPS6045852B2 (en) | 1981-12-07 | 1981-12-07 | Method for producing placental gonadotropic hormone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56197380A JPS6045852B2 (en) | 1981-12-07 | 1981-12-07 | Method for producing placental gonadotropic hormone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5899421A JPS5899421A (en) | 1983-06-13 |
| JPS6045852B2 true JPS6045852B2 (en) | 1985-10-12 |
Family
ID=16373544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56197380A Expired JPS6045852B2 (en) | 1981-12-07 | 1981-12-07 | Method for producing placental gonadotropic hormone |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6045852B2 (en) |
-
1981
- 1981-12-07 JP JP56197380A patent/JPS6045852B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5899421A (en) | 1983-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2749272B2 (en) | Purification method of anthracycline glycoside | |
| US4528186A (en) | Method of producing human epidermal growth factor | |
| CN108187608A (en) | A kind of crystallinity aluminium salt lithium ion absorbent particles and preparation method thereof | |
| CN102600792B (en) | A kind of preparation method of the titanium dioxide particle adsorbent for drink water purifying | |
| US4482542A (en) | Antacid material based on magnesium aluminium hydroxide and the preparation thereof | |
| JP3178831B2 (en) | How to separate amino acids | |
| JPS6045852B2 (en) | Method for producing placental gonadotropic hormone | |
| CN116284233A (en) | Method for preparing itracin | |
| ZA200307303B (en) | Process for preparing a group VIII-metal containing catalyst, use thereof for preparing an alkenyl carboxylate. | |
| CN117065719B (en) | Mineral composite defluorination material and preparation method and application thereof | |
| JPWO2000038524A1 (en) | Aluminosilicate antibacterial agent | |
| JP2559125B2 (en) | Method for producing antibacterial zeolite | |
| JPH0457680B2 (en) | ||
| JP3832961B2 (en) | Regeneration method of radium adsorbent | |
| JP3097928B2 (en) | Cation adsorbent | |
| WO2003014135A1 (en) | Method for purification of acarbose | |
| JP3901278B2 (en) | Method for purifying hydrogen peroxide water | |
| AU6716290A (en) | Improved chill proofing of beer | |
| EP1446411A1 (en) | Acarbose purification process | |
| JPH05155612A (en) | Ion-exchange method of zeolite | |
| HU214452B (en) | Process for producing salts of deferoxamin b with high purity | |
| JP2548874B2 (en) | Chromatographic separation packing material | |
| JPH0662668B2 (en) | Glutathione purification method | |
| JPS641118B2 (en) | ||
| JPH062580B2 (en) | Boehmite-like aluminum hydroxide, its production method and oral phosphate adsorbent containing it |